Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.onclive.com/view/navtemadlin-with-ruxolitinib-leads-to-svr-benefit-in-tp53-wild-type-myelofibrosis

ONCLIVE
08 Jul 2023